OrthoPediatrics (NASDAQ:KIDS – Get Rating) and Vapotherm (NYSE:VAPO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.
Profitability
This table compares OrthoPediatrics and Vapotherm's net margins, return on equity and return on assets.
Get
OrthoPediatrics alerts:
| Net Margins | Return on Equity | Return on Assets |
| OrthoPediatrics | -10.88% | -7.49% | -5.37% |
| Vapotherm | -102.94% | -142.53% | -47.74% |
Insider & Institutional Ownership
71.5% of OrthoPediatrics shares are held by institutional investors. Comparatively, 69.7% of Vapotherm shares are held by institutional investors. 29.5% of OrthoPediatrics shares are held by company insiders. Comparatively, 10.6% of Vapotherm shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Volatility & Risk
OrthoPediatrics has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Vapotherm has a beta of -0.22, meaning that its stock price is 122% less volatile than the S&P 500.
Valuation and Earnings
This table compares OrthoPediatrics and Vapotherm's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| OrthoPediatrics | $98.05 million | 10.85 | -$16.26 million | ($0.60) | -83.15 |
| Vapotherm | $113.29 million | 0.47 | -$59.80 million | ($3.71) | -0.54 |
OrthoPediatrics has higher earnings, but lower revenue than Vapotherm. OrthoPediatrics is trading at a lower price-to-earnings ratio than Vapotherm, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and target prices for OrthoPediatrics and Vapotherm, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| OrthoPediatrics | 0 | 0 | 4 | 0 | 3.00 |
| Vapotherm | 1 | 4 | 0 | 0 | 1.80 |
OrthoPediatrics presently has a consensus price target of $62.50, indicating a potential upside of 25.28%. Vapotherm has a consensus price target of $4.75, indicating a potential upside of 136.32%. Given Vapotherm's higher possible upside, analysts plainly believe Vapotherm is more favorable than OrthoPediatrics.
Summary
OrthoPediatrics beats Vapotherm on 11 of the 14 factors compared between the two stocks.
About OrthoPediatrics
(Get Rating)
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
About Vapotherm
(Get Rating)
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
